| Code | 0072A | ||||||||||
| MA number | 44/0165/12-S | ||||||||||
| Product Form: | con inf 1x60 ml/600 mg (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Fresenius Kabi s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 21.03.2012 |
| SPC: |
SPC_Carboplatin Kabi 10 mg_ml_07.2024.pdf
|
| PIL: |
PIL_Carboplatin Kabi 10 mg_ml_07.2024.pdf
|
| Safety feature | Yes |
| Data update: | 29.05.2018 |
